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Abstract
Dengue virus was the first microorganism that was shown to induce generation
of antigen-specific suppressor T (TS) cells in mice. The cascade of the three
generations of TS cells (TS1, TS2, TS3) and their secretary products, the
suppressor factors (SF1, SF2), was delineated. The TS pathway was proposed to
be protective through inhibition of the production of enhancing antibody, which
may enhance the severity of dengue disease. The currently second most favoured
mechanism of severe dengue disease is the ‘cytokine tsunami’. During the last
decade, suppressor/regulatory T cells have been studied in greater detail using
modern techniques in various diseases, including viral infections. This brief review
discusses the role of dengue-specific suppressor T cells in protection and/or
induction of severe dengue disease in view of our current understanding of
suppressor/regulatory T cells.
Introduction
The immune response involves a complex series of interac-
tions between macrophage-like cells (Mf), T and B cells,
initiated by an antigenic stimulus. The modulators of the
immune response are suppressor/regulatory T cells, which
may be antigen-specific or nonspecific in effecter functions
(Chaturvedi, 1984). The immune response is of great
importance in recovery from infections but may also result
in immunopathology in several infections, and therefore
regulation of the immune response is crucial in infectious
diseases. The earliest studies on suppressor T cells and their
products mediating immunosuppression were done in
the 1970s using synthetic antigens (Fig. 1). With the avail-
able technology at that time, a sequential generation of up to
three subpopulations of suppressor T cells (TS1, TS2, TS3)
and their secretary products (suppressor factor) were
described that transmitted the signal to suppress antigen-
specific humoral and/or cell-mediated immune responses
(reviewed by Benacerraf & Germain, 1981). For the first
time microorganism-induced suppressor T-cell cascades
(Fig. 1) were delineated in dengue virus (DV)-infected mice
(Tandon et al., 1979; Shukla & Chaturvedi, 1981, 1984;
Chaturvedi, 1984) and then in Japanese encephalitis virus
(JEV)-infected mice (Mathur et al., 1983, 1984). The role
of suppressor T cells in preventing immunopathology in
DV and their role in the persistence and latency of JEV
infection were reported (Chaturvedi, 1984; Mathur et al.,
1987a, b). In some cases, regulatory immune responses
downregulate pathogenic responses, whereas in others
they enhance pathogen survival leading to chronic infection.
A comparison of the suppressor T-cell cascades induced
by different antigens is summarized in Fig. 1. Further
understanding of suppressor T cells was restricted due to
the lack of technology to detect definitive cell markers. By
the late 1980s, interest in suppressor T cells had declined and
their existence was even considered doubtful. An explicit
narration of the rise and downfall of suppressor T cells and
their re-emergence as a regulatory T cell in recent times can
be found in the excellent review by Steinman (2007).
Sakaguchi et al. (1995) were the first to describe a
naturally occurring subset of CD41 cells that expressed
interleukin-2 (IL-2) receptor a-chains (CD25) in mice.
Studies demonstrated that this subset of cells inhibits
antitumour immunity, prevents a wide range of autoim-
mune disorders including inflammatory bowel disease and
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autoimmune diabetes, and induces tolerance to skin allo-
grafts (Asano et al., 1996). This vindicated the credibility of
the idea of suppressor T cells and refocused attention on this
subset of cells. This led to extensive characterization of
regulatory T-cell properties in vitro and development of a
simple in vitro assay for their functions. This made analysis
of regulatory T cells possible in rodents and humans
(Takahashi et al., 1998; Thornton & Shevach, 1998). This
subgroup of cells has since been described in humans and, as
in mice, constitutes about 5–10% of peripheral CD41
T cells (Jonuleit et al., 2001). These cells can be obtained
from peripheral blood, thymus and secondary lymphoid
organs including tonsils and spleen. McHugh et al. (2002)
were the first to identify the glucocorticoid-induced tumour
necrosis factor receptor family-related gene (GITR) as a
potential marker of regulatory T cells. Subsequently, it was
shown that for the development and function of natural
CD41CD251 regulatory T cells, Foxp3, encoding a member
of the forkhead transcription factor family, is a ‘master
control gene’. This showed that abnormality in regulatory
T cells can cause human autoimmune disease, allergy and
inflammatory bowel disease, as in the human syndrome
Immune dysregulation, polyendocrinopathy, enteropathy,
X-linked (IPEX) (Fontenot et al., 2003; Hori et al., 2003;
Khattri et al., 2003). Klein et al. (2003) were the first to
report the dynamics of in vivo regulatory T-cell suppression.
Dysfunction of a CD41CD251 regulatory T-cell subset has
been implicated in the pathogenesis of multiple sclerosis and
rheumatoid arthritis (Ehrenstein et al., 2004; Viglietta et al.,
2004) and the presence of CD41CD251 regulatory T cells
has been associated with improved outcome in lung trans-
plant recipients (Meloni et al., 2004). These observations
excited interest in exploring cell-based immunotherapy with
CD41CD251 regulatory T cells to treat autoimmunity or
promote graft acceptance and tolerance. Battaglia et al.
(2005) have reported that rapamycin can be used in ex vivo
expansion protocols to generate sufficient numbers of
CD41CD251 regulatory T cells for cell-based immunother-
apy. The role of these cells has been described in a number of
viral infections, e.g. retro, herpes and picorna viruses (Mills,
2004; Suvas & Rouse, 2005; Vahlenkamp et al., 2005;
Schneider-Schaulies & Dittmer, 2006). The present paper
reviews our existing knowledge of suppressor/regulatory T
cells and its implication in the pathogenesis of severe dengue
disease. Due to space constraints only selected works have
been cited.
Different types of regulatory T cells
Regulatory T cells are either naturally occurring (developing
in the thymus) or the adaptive antigen-specific regulatory T
cells that can be induced from naı¨ve CD41CD25 or
CD81CD25 T cells in the periphery under the influence of
semimature dendritic cells (DCs), IL-10, transforming
growth factor-b (TGF-b) and possibly interferon-a (IFN-
a) (Bluestone & Abbas, 2003; Mills, 2004). Figure 2
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Fig. 1. Comparison of different suppressor T-cell
cascades. Antigens induce a suppressor pathway
in mice that involves sequential production of up
to three generations of T suppressor cells (TS1,
TS2, TS3). Ts1 cells produce a soluble suppressor
factor (SF1), which transmits the signal via
macrophages to generate TS2 cells, which pro-
duce a soluble suppressor factor (SF2) to recruit
TS3 cells, which suppress antigen-specific
immune response. ABA, azobenzenarsonate;
DNP, dinitrophenyl; DV, dengue type 2 virus; GAT,
L-glutamic acid60-L-alanine30-L-tyrosine10; GT,
L-glutamic acid50-L-tyrosine50; JE, Japanese
encephalitis virus; KLH, keyhole limpet haemo-
cyanin; SRBC, sheep red blood cells (Benacerraf
& Germain, 1981; #Chaturvedi, 1984; Chaturvedi,
1997; Mathur et al. 1983, 1984, 1986a).
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summarizes the evolution of the immune response and the
four major subsets of regulatory T cells.
Natural regulatory T cells
These are recognized by their constitutive expression of CD4
and CD25 and the transcription factor foxP3 and surface
CD152. They depend on TGF-b for their generation and the
suppressive activity. They can induce indoleamine 2,3-
dioxygenase (IDO) in appropriate DCs by CD152-mediated
ligation of CD80/86. They are generated in the thymus and
represent about 5–10% of CD41CD8 thymocytes in
humans and migrate to populate the periphery and do not
recirculate (Stassen et al., 2004). The number of Treg cells
generated depends on the diversity of major histocompat-
ibility (MHC) class II/peptide complexes in the thymus,
leading to the selection of Treg cells with diverse T-cell
antigen receptors (TCRs) (Pacholczyk et al., 2002). Recently
it has been reported that Hassall’s corpuscles present in the
thymus produce chemical signals, the thymic stromal lym-
phopoietin (TSLP), that activates dendritic cells in the
thymus to induce development of the Treg cells (Watanabe
et al., 2004; Liu et al., 2007). This means that the thymus is
providing central tolerance not only through clonal deletion
as was previously proposed by the clonal selection theory,
but also through clonal conversion. Natural Treg cells appear
to play a role in regulating chronic infections, such as HIV
and hepatitis C (Belkaid & Rouse, 2005).
Th3 cells
Th3 CD41 regulatory cells were identified during the course
of investigations into the mechanisms associated with oral
tolerance. Th3 regulatory cells form a unique T-cell subset
that primarily secretes TGF-b, provides help for IgA and has
suppressive properties for both Th1 and Th2 cells. Th3-type
cells are distinct from Th2 cells, as CD41 TGF-b-secreting
cells with suppressive properties have been generated from
IL-4-deficient animals. In vitro differentiation of Th3 cells
from Th precursors from TCR transgenic mice is enhanced
by culture with TGF-b, IL-4, IL-10 and anti-IL-12. Th3
regulatory cells are triggered in an antigen-specific fashion
but suppress in an antigen-nonspecific fashion (Weiner,
2001). Recent results of Carrier et al. (2007) suggest that
TGF-b-derived Foxp3(1)CD25(1/) Th3 regulatory cells
represent a different cell lineage from thymically derived
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Fig. 2. Generation of immune response and
different types of regulatory T cells. A fine
balance of interdependent cytokines deter-
mines Th1 or Th2 bias in the response. In
general, four types of regulatory T cells are
generated, natural or antigen-induced.
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CD25(1) regulatory T cells in the periphery but may play an
important role in maintaining thymic regulatory T cells in
the peripheral immune compartment by secretion of TGF-b.
Tr1 cells
This comprises a subset of CD41 helper T cells that are
dependent on IL-10 for their differentiation and their
regulatory properties. They secrete high levels of IL-10, no
IL-4 and no or low levels of IFN-g and may express markers
associated with Th2 cells and repressor of GATA (ROG) but
not fox3. They express high levels of surface CD152 like
natural regulatory T cells and can induce IDO and trypto-
phan catabolism in appropriate DCs (Mills, 2004).
Suppressor T cells
Like Tr1 cells, CD81CD25 suppressor T cells need the
presence of IL-10 for induction, and IL-10 may be involved
in the downregulation of dendritic cell costimulation and
the upregulation of ILT-3 and ILT-4 (in human DCs). IL-10-
secreting Tr1 cells have been implicated in the regulation of
immune responses elicited by viruses (Iwashiro et al., 2001)
and bacteria (McGuirk et al., 2002), etc.
Besides these, some other cells have also been termed
regulatory T cells. A subpopulation of ‘anergic’ CD41 cells is
generated by antigen stimulation without costimulation.
They are characterized by an intrinsic increase in their
threshold for antigen stimulation, which may be maintained
by expression of E3 ubiquitin ligases such as GRAIL, c-cbl
and Itch. They adsorb stimulatory cytokines such as IL-2 at
the sites of antigen presentation, thus acting as regulatory
T cells. The anergic cells differ from the regulatory T cells
functionally, in expression of molecular signature and in
pathological effecter cell responses (Knoechel et al., 2006).
They have been generated in vivo during certain infections,
e.g. rabies virus (Hirai et al., 1992). Other cells, for example
natural killer cells (NKTs) and gd T cells, have also been
categorized as regulatory T cells (Mills, 2004). The distribu-
tion and trafficking of regulatory T cells in various tissues
depends on distinct chemokine receptors and integrin
molecules (Fig. 3).
Dengue virus infection
DV belongs to the family Flaviviridae and is transmitted by
Aedes mosquito, which is found in tropical and subtropical
regions around the world, predominantly in urban and
semiurban and now in rural areas also. DV has four
antigenically related serotypes (1–4) and causes self-limiting
milder febrile illness, dengue fever (DF), or a severe disease,
dengue haemorrhagic fever (DHF). The main amplifying
host of the virus are humans. Infection by one serotype of
DV provides long-lasting immunity against the same but
confers only partial and transient immunity against infec-
tion by the other three serotypes. The prevalence of dengue
has grown dramatically and the disease is endemic in more
than 100 countries in Africa, the Americas, the eastern
Mediterranean, South-East Asia and the western Pacific.
South-East Asia and the western Pacific are most seriously
affected. Two-fifths of the world’s population is now at risk
from dengue. The World Health Organization currently
estimates there may be 50 million cases of dengue infection
worldwide every year and estimated that 500 000 cases of
DHF require hospitalization each year, of whom a very large
proportion are children (Rigau-Perez et al., 1998; Agarwal
et al., 1999a; Malavige et al., 2004). The characteristic
features of DHF are increased capillary permeability without
morphological damage to the capillary endothelium, altered
number and functions of leucocytes, increased haematocrit
and thrombocytopoenia. Extensive plasma leakage in var-
ious serous cavities of the body including the pleura,
pericardium and peritoneal cavities in DHF may result in
profound shock, the dengue shock syndrome (DSS). There
is no specific therapy or a vaccine to prevent dengue disease.
(Halstead, 1993, 2002; Malavige et al., 2004).
Regulatory T-Cells 
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Tumor, Graft 
CCL22
Lymph Node
CXCL19
Inflammatory Tissue 
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Fig. 3. Distribution of regulatory T cells in var-
ious tissues. Distinct chemokine receptors and
integrin molecules are implicated in regulatory
T-cell organ/tissue trafficking and compartmen-
talization. Bone marrow-derived CXCL12 med-
iates Treg-cell bone marrow trafficking.
Environmental CCL22 mediates regulatory T-cell
trafficking into human ovarian cancer and
mouse cardiac grafts. The lymphoid homing
molecules CCR7 and CD62L may facilitate lym-
phoid homing of regulatory T cells. Certain CC
chemokines and integrins may mediate regula-
tory T-cell trafficking into inflammatory tissues/
organs (Wei et al., 2006).
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Immune response to DV
The first line of the innate host defence against invading DV
in skin, where it replicates after the initial bite by an infected
mosquito, is provided by the macrophage-lineage cells,
interstitial DCs and Langerhan cells (LCs). Early activation
of NK cells and type-I IFN-dependent immunity may limit
viral replication at the early stages of DV infection (Shresta
et al., 2004a).
DV is composed of 10 viral proteins, the core and
membrane proteins, the envelope (E) glycoprotein, and
seven nonstructural (NS) proteins. Anti-E antibodies inhibit
DV binding to cells, neutralize viral infectivity in vitro, show
a variable degree of cross-reactivity among the DV serotypes
and protect mice from DV challenge on passive transfer
(Kaufman et al., 1987; Roehrig et al., 1998). The uptake of
DV1 nonneutralizing antibody complex into monocytic
cell lines and primary human monocytes in vitro is
enhanced through binding to the Fc-receptor, known as
antibody-dependent enhancement of infection (Morens &
Halstead, 1990). Complement-mediated lysis of DV-
infected cells can be triggered by antibodies against NS1
in vitro but they may cross-react with endothelial cells leading
to their activation and expression of cytokines, chemokines
and adhesionmolecules, resulting in cell damage (Schlesinger
et al., 1987; Lin et al., 2005). DV-reactive CD41 and CD81
T cells are stimulated mainly by NS3 protein, which produces
high levels of IFN-g as well as TNF-a, TNF-b, and chemo-
kines upon interaction with DV-infected antigen presenting
cells (APCs), and are efficient at lysis of DV-infected cells
in vitro (Kurane et al., 1991; Loke et al., 2001).
Role of T cells in dengue
CD41 T lymphocytes play a central role in regulating the
cell-mediated immune response to infection. Some CD41
T cells can develop into Cytotoxic T lymphocytes (CTL) and
can attack B cells, macrophages and DCs (Chinen & Shearer,
2005; Wing et al., 2005). The activated CD41 T cell is
capable of recognizing the antigen and act by releasing
cytokines in response. The interaction between antigen-
specific CD41 T cells and macrophages forms the basis of
the delayed-type hypersensitivity response, which is one of
the main effecter mechanisms in eliminating infections with
intracellular organisms (Wing et al., 2005; Huber &
Schramm, 2006). The NS3 is an important target of CD81
T cells in secondary DV infection and the activation and
expansion of DV-specific T cells is greater in subjects with
DHF than in those with DF, which may play an important
role in the pathogenesis of DHF (Simmons et al., 2005). The
results highlight the importance of NS3 and cross-reactive T
cells during acute secondary infection.
A DV-specific memory lymphocyte response has been
detected even 20 years after a primary infection by DV (Sierra
et al., 2002). Mongkolsapaya et al. (2003) have studied DV-
specific T-cell responses in Thai children. During acute
infection, few dengue-responsive CD81 T cells were recov-
ered; most of those present showed an activated phenotype
and were undergoing programmed cell death. Many DV-
specific T cells were of low affinity for the infecting virus and
showed higher affinity for other, probably previously encoun-
tered strains. Cross-reactive DV-specific T cells seem to show
suboptimal degranulation but high cytokine production,
which may contribute to the development of the vascular
leak characteristic of DHF (Mongkolsapaya et al., 2006). The
prior infection history of the individual as well as the
serotypes of the primary and heterologous secondary viruses
influences the nature of the secondary response. Profound T-
cell activation and death may contribute to the systemic
disturbances leading to DHF, and original antigenic sin in
the T-cell responses may suppress or delay viral elimination,
leading to higher viral loads and increased immunopathol-
ogy. High levels of T-cell activation, coupled with rapid cell
death and the domination of the cellular immune response by
cells with a low affinity for the infecting virus, may suppress
or delay virus clearance leading to high viral loads and
increased immunopathology (Stephenson, 2005).
Immunopathogenesis of DHF
Despite extensive studies, the pathogenesis of DHF is still
not fully understood. The mechanisms that have been
considered include immune complex disease, antibodies
cross-reacting with vascular endothelium, enhancing anti-
bodies, complement and its products, memory T cells,
various soluble mediators including cytokines, selection of
virulent strains and virus virulence (Halstead, 1993; Cha-
turvedi et al., 1997, 2000, 2005, 2006a; Mongkolsapaya,
2003; Cologna et al., 2005; Lin et al., 2005). Both viral and
host factors influence the disease severity. The risk of severe
disease is higher in children, with worse outcome with the
Asian strain whereas American strains of DV largely affect
the adult population and produce milder disease. This
correlates with the structural difference in the two strains of
DVand the host genetics (Leitmeyer et al., 1999; Watts et al.,
1999; Rico-Hesse, 2003; Cologna et al., 2005; Chaturvedi
et al., 2006b).
Disturbed cytokine cascade is the most supported
hypothesis (Pang et al., 2007). The key cytokines that have
been associated with DHF include the shift from Th1-type
response in DF to the Th2-type cytokine response in DHF
with increased levels of IL-10 and IL-4 (Chaturvedi et al.,
1999). The increased levels of TNF-a (reviewed by Chatur-
vedi et al., 2000), TGF-b (Agarwal et al., 1999b) and IL-8
(Raghupathy et al., 1998) have been associated with DHF,
and IL-12 with DF (Pacsa et al., 2000). Patients with defects
in the IL-12 receptor or IFN-g receptor have abnormal
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responses to IL-12 or IFN-g and a failure to produce normal
levels of IFN-g (Catherinot et al., 2005; Wood et al., 2005).
We have proposed a mechanism that may explain the
pathogenesis of DHF (Chaturvedi et al., 2000). DVreplicates
in macrophage-like cells and rapidly induces the CD41
T cells to produce a unique cytokine, the cytotoxic factor
(hCF) (Agarwal et al., 1998). hCF induces macrophages to
produce free radicals, nitrite, reactive oxygen and peroxyni-
trite (Misra et al., 1996, 1998). The free radicals, besides
killing the target cells via apoptosis, also directly upregulate
production of proinflammatory cytokines IL-1, TNF-a, IL-8
and hydrogen peroxide in macrophages. The change in
relative levels of IL-12 and TGF-b shifts a Th1-dominant
response to a Th2-biased response, resulting in an exacerba-
tion of dengue disease and death of the patients. Vascular
permeability is increased due to the combined effect of
histamine, free radicals, proinflammatory cytokines and the
products of the complement pathway, etc (Fig. 4). Thus, the
key player appears to be hCF. Furthermore, the elevated
levels of hCF autoantibodies protect the patients against the
development of severe forms of DHF and therefore it may be
useful as a prognostic indicator (Chaturvedi et al., 2001).
Among the several hypotheses proposed to explain the
pathogenesis of severe dengue disease, two are from land-
mark studies. First was the role of enhancing antibodies
(Halstead, 1970) and the second was the demonstration of a
shift from a Th1 response in mild dengue to a Th2-response
in severe DHF (Chaturvedi et al., 1999) associated with
disturbance to the fine balance of the cytokine cascade,
resulting in a ‘cytokine storm’, which causes all the patholo-
gical lesions (Chaturvedi et al., 2000). Given the severity and
speed with which the clinical condition of the patient
deteriorates, with multiorgan involvement, we prefer the
term ‘cytokine tsunami’, i.e. it washes away every thing in its
tide.
Suppressor T cells in dengue
DV was the first infectious agent against which TS cells were
demonstrated and used to delineate the sequential events in
the suppressor pathway that has been presented here as a
model of the chain of events in an infection.
Induction of suppressor T cells
In DV infection of mice, the virus replicates in the spleen
and other organs (Chaturvedi et al., 1978), thus overloading
with antigen; the Macrophage (Mf) are killed or become
functionally detective (Chaturvedi et al., 1982, 1983; Gulati
et al., 1982), and the presence of immune complexes have
been shown in human infection. Therefore, the above
factors, singly or combined in various proportions, provide
a strong stimulus for the generation of suppressor cells. DV
induces suppressor cells both by i.p. or i.c. routes and
activity lasts for 3 weeks (Shukla & Chaturvedi, 1985). The
phenotype of DV-induced TS1 and TS2 cells is CD81
(mouse = Ly231) and that of TS3 cells is CD41. The inducer
CD4+ 
T Cell
CF
CF2
IL-12
TGF-β
IFN-γ
IL-2
NO+O2- Mast
Cells
IL-4
IL-5
IL-6
IL-10
IL-13
IL-18
Histamine
IL-1
IL-8
TNF-α
 DHF
Anti-CF Autoantibody
DV
Mφ Mφ
Th1
Th2
Suppressor/
Regulatory
T Cell Fig. 4. Interaction of various cytokines/secretary
products during dengue virus infection. Any shift
in the bias towards the Th2 response precipitates
dengue haemorrhagic fever (DHF). Thin lines,
positive induction; thick lines, damaging effect;
dashed lines, inhibition.
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cells of suppressor activity are CD41 T cells. In the DV
model, TS1 and TS2 appear to be suppressor cells while the
TS3 cells appear to induce suppression of B-cell activity
(Chaturvedi, 1984).
Production of soluble suppressor factors
TS cells may mediate their activity either through direct
contact of interacting cells or through elaboration of soluble
factors. In the DV model the TS1 cells produce a soluble
suppressor factor (SF1) that can be extracted from cells or is
secreted in culture fluid (Shukla & Chaturvedi, 1981, 1984).
SF1 induces another subpopulation of T cells in vivo and
in vitro to produce another soluble suppressor factor (SF2)
that is prostaglandin-like (Chaturvedi & Shukla, 1981;
Chaturvedi et al., 1981).
Suppressor T cell cascade
DV-infected mice develop DVantigen-specific immunosup-
pression, which has been shown to be mediated by a cascade
of three generations of TS cells and their secretary soluble
suppressor cytokines (SF) with Mf transmitting the signals
in between (Fig. 5). DV-infected Mf transmit the signal to
recruit TS1 cells, which secrete a suppressor cytokine, SF1.
The suppressor signal of SF1 is transmitted via live syngeneic
Mf to recruit a second subpopulation of suppressor T cells
(TS2), which produce another soluble, prostaglandin-like
suppressor cytokine (SF2). Prostaglandin-producing sup-
pressor cells have also been shown in hepatitis C virus
(HCV) patients (Marinho et al., 2002). SF2 induces produc-
tion of a third subpopulation of suppressor T cells (TS3),
which suppresses the humoral immune response in an
antigen-specific and genetically restricted manner (Shukla
& Chaturvedi, 1981, 1982, 1983, 1984, 1985; Chaturvedi,
1984; Chaturvedi et al., 1985a, b). A few reports show that
regulatory T cells are specific for pathogen-derived antigens,
e.g. mouse and humans infected with JEV (Mathur et al.,
1984, 1987a, b, 1991) and humans infected with HCV and
other viruses (Mills, 2004). The effects of prostaglandin E2
(PGE2) on Ig production consist of its indirect effects
through T cells and its direct effects on B cells. The outcome
of the effects can be upregulatory or downregulatory,
depending on whether resistant or sensitive T cells are
involved (He et al., 2002). COX-2-mediated PGE2 upregu-
lates IL-10, which downregulates IL-12 production and the
APC function of bone-marrow DCs (Harizi et al., 2002).
PGE1 inhibits all the adhesion molecule expression, cyto-
kine production and T-cell proliferation in the presence of
IL-18 (Takahashi et al., 2005). Recently it has been reported
DV Mφ TS1
Naïve
T cell 
SF1 TS2
SF2
Mφ Naïve
T cell
Naïve
T cell 
TS3
Th3? Tr1?
TGF-
β
IL-10
DV-Specific
Immunosupression
CD8
CD8
CD4
PGE-like
Fig. 5. Dengue virus (DV) induces a suppressor
pathway in mice which involves sequential pro-
duction of three generations of suppressor T cells
(TS1, TS2, TS3). TS1 cells produce a soluble
suppressor factor (SF1), which transmits the sig-
nal via macrophages to generate TS2 cells, which
produce a prostaglandin-like soluble suppressor
factor (SF2) to recruit TS3 cells, which suppress
the antigen-specific immune response. It is not
known whether TS3 is Tr1 or Th3 or is a separate
type of regulatory T cell. The properties of these
suppressor cells and their products have been
discussed as a model in relation to pathogenesis
of the disease. It is concluded that the generation
of the suppressor pathway is a protective as well
as destructive phenomenon.
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that in resting CD41CD25 T cells, treatment with PGE2
induces FOXP3 expression, which may be the mechanism
used by these cells to suppress effecter T cells (Baratelli et al.,
2005; Mahic et al., 2006).
Role of macrophages in transmission of
DV-specific cytokine signal
Cytokines transmit their signal via receptors on target cells.
The receptors studied for DV-induced SF1 are presented in
Table 1. The study undertaken to investigate the intermedi-
ary role of Mf in transmission of signal from TS1 to TS2
showed that live syngeneic macrophages adsorb SF1 and
transmit the signal to naive T cells to recruit TS2. This is not
possible with killed Mf or in the absence of live Mf (Shukla
& Chaturvedi, 1982). Furthermore, transmission of sup-
pressor signal from SF1-adsorbed Mf to lymphocytes
occurs only by physical contact of the plasma membranes
of the interacting cells and not if they are separated by cell-
impermeable membranes (Shukla & Chaturvedi, 1983). The
suppressive function of natural and inducible regulatory
T cells has been shown to be mediated either through
secretion of immunosuppressive cytokines or through cell–
cell contact (Mills, 2004). Pretreatment of Mf with the
calcium channel blockers that block the influx of calcium
inhibit transmission of the suppressor signal from TS1 to
TS2 cells in a dose-dependent manner. The presence of
calcium ions is obligatory for transmission of the suppressor
signal (Khare & Chaturvedi, 1995). Similarly, nitrous oxide
also serves as an intracellular signal in the transmission of
suppressor signal in Mf (Khare & Chaturvedi, 1997).
SF1 is composed of two polypeptide chains (a and b)
(Bhargava et al., 1990). Scatchard analysis showed the
presence of both high- and low-affinity SF receptor sites
(SF-R) onMf. SF-R purified from normal mouse peritoneal
Mf is composed of two polypeptide chains (a and b), which
are obtained in pure form by HPLC of dithiothreitol- and
iodoacetamide-treated SF-R (Mukherjee et al., 1993a). Both
high- and low-affinity receptors are present on Tand B cells.
Both the a- and the b-chains of SF purified by HPLC bind to
Mf, but only the a-chain binds to SF-R protein while the b-
chain of SF binds to H-2A determinants on Mf (Mukherjee
et al., 1993b, 1994). SF binds to both high- and low-affinity
SF-R on Mf and that bound to high-affinity receptors is
internalized through receptor-mediated endocytosis. Pre-
treatment of Mf with anti-SF-R-antiserum and didansylca-
daverine, a potent inhibitor of endocytosis, inhibits this.
Internalized SF is degraded by lysosomal activity and is
transported to a site other than SF-R on the Mf membrane
for recruitment of TS2 cells. As SF requires binding to H-2A
and SF-R for mediation of suppression, the binding of H-2A
occurs with degraded SF within the cell (Fig. 6). Thus, SF
is internalized, degraded and binds to H-2K antigen before
its recognition by native T cells (Tripathi et al., 1997).
Role of TS cells in the immunopathogenesis
of DHF
Regulatory T cells are a double-edged sword. They are
beneficial to the host by preventing immunopathology and
help in the development of immune memory. On the other
hand, they help the pathogen to establish a chronic infec-
tion. TS cells, including memory TS cells, have been shown
to play an important role in the continued battle between
the virus and immunological memory cells, resulting in
latency and persistence of viruses. JEV is known to produce
a persistent and latent infection in mice (Mathur et al.,
1986a, b) and human patients (Mathur et al., 1991) that can
be reactivated. Immunological memory is retained in the
latent JEV infection of mice (Kulshreshtha et al., 1988) and
the reactivated JEV in latently infected mice induces a
secondary immune response (Mathur et al., 1987a). The
presence of memory TS cells in mice latently infected with
JEV has been shown, and these can be stimulated to generate
secondary TS cells by exogenous or endogenous virus
challenge (Mathur et al., 1987b). Sheridan et al. (2006) have
reported that latent virus influences the generation and
maintenance of CD1 T-cell memory. This phenomenon
could help in the persistence of the virus.
Early activation of NK cells and type-I IFN-dependent
immunity may limit viral replication at the early stages of
DV infection. IFN-a/b is critical for early immune responses
Table 1. Receptors on various cells for DV-induced suppressor factor
Cell
No. of receptors/
cell (affinity)
No. of polypeptide
chains in cytokine
No. of polypeptide
chains in receptor
Sites of binding of
cytokine on cells References
Macrophage M: 54 000 (HA)
M: 1.78 106 (LA)
a chain
b chain
a chain
b chain
SFa: SFRb SFb: H-2A Mukherjee et al. (1993a, b, 1994),
Tripathi et al. (1997)
T cell T: 35 000 (HA)
T: 0.72 106 (LA)
B cell B: 16 000 (HA)
B: 0.33 106 (LA)
M, macrophage; T, T lymphocyte; B, B lymphocyte; HA, high-affinity receptor; LA, low-affinity receptor; SFR, receptor for SF.
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to DV infection while IFN-g-mediated immune responses
are crucial for both early and late clearance of DV infection
in mice (Shresta et al., 2004a). Early activities of NK cells,
B cells and IgM, and later actions of IFN-g and IgG are likely
to play a role in the defence against DV infection (Shresta
et al., 2004b). Failure of NK cells to contain DV replication
may result in severe DHF/DSS, which is associated with
Th2-type response (Chaturvedi et al., 1999, 2000, 2006a, b).
A similar enhancement of Th-2-type response and severe
disease has been reported in Bordetella pertussis infection in
the absence of NK cells (Byrne et al., 2004). Histamine may
mediate deleterious effects on vascular permeability in
patients with DHF (Chaturvedi et al., 2000) and can also
modulate the Th1/Th2 cell balance.
A balanced Th1 and Th2 response controls the immune
response to microorganisms. Severe dengue disease is asso-
ciated with a predominant Th2 response and markedly
increased levels of a number of cytokines, including IL-10
and TGF-b (Table 2). PGE is known to enhance the levels of
intracellular cAMP, whichblocks the development of IL-12
responses (Van der Pouw Kraan et al., 1995). SF2 is a PGE-
like molecule (Chaturvedi et al., 1981; Shukla & Chaturvedi,
1981), and may inhibit IL-12 production in DV infection. By
suppressing protective Th1 responses the regulatory T cells
may enhance the Th2 response and increase the infection-
induced immunopathology. Antigen-specific Tr1 or Th3
cells secrete IL-10 and/or TGF-b, but no IL-4 and little or
no IFN-g, and are induced by semimature dendritic cells
under the influence of regulatory cytokines, including IL-10,
TGF-b and IL-4. Tr1 or Th3 cells are capable of suppressing
Th1 or Th2 responses and functions in infection (Mills &
McGuirk, 2004). Loss of suppressor of cytokine signalling
(SOCS3) in T helper cells results in reduced immune
responses and hyperproduction of IL-10 and TGF-b (Kinjyo
et al., 2006). Suppression of Th1 response by Tr1 or Th3 cells
in DV infection may result in pathogen-induced immuno-
pathology. It is not known whether the TS3 cells described in
DV infection are Tr1 or Th3 or a separate lineage. McGuirk
& Mills (2002) have shown that pathogen-specific regula-
tory T cells provoke a shift in the Th1/Th2 paradigm in
immunity to infectious diseases. Is this true in DHF also
where a shift to Th2 response results in severe disease. Both
the regulatory T cells and Th2 cells secrete IL-10 and TGF-b,
thus disturbing the fine balance in the different cytokines
and causing a ‘cytokine tsunami’ and severe dengue disease.
The DV-induced suppressor pathway suppresses antigen-
specific antibody production, including that of the enhan-
cing antibody. Thus, increased replication of the virus
mediated by the enhancing antibody and the immuno-
pathology mediated by the immune complex is prevented.
Naïve
T
cells
H-2K
SF-Rα SF-Rβ
SF
Fusion with lysosome
for lysosomal activity
SF-SF-R complex
internalization
Anti-SF-R Ab
and
Didansylcadaverine
Monensin and NH4Cl
Proteolytic cleaved SF
loaded on H-2K antigen
H-2K with SF peptide complex
Activated TS2 cellTS2
cells
Fig. 6. Internalization of suppressor factor (SF)
through suppressor factor receptor (SF-R)
expressed on macrophages after DV infection: SF
binds to SF-R on macrophages and complex is
internalized into coated pits that enclosed the
vesicular compartment. The SF-SF-R complex
required for initiating suppressor activity is inhib-
ited by anti-SF-R-Ab and didansylcadaverin,
which is an inhibitor for receptor-mediated inter-
nalization. The vesicular compartment loaded
with complex is fused with lysosomes for clea-
vage of SF into peptides. The lysosomal activity of
lysosomes is inhibited by monensin and NH4Cl.
The proteolytically cleaved SF is loaded on H-2K
antigen and the complex is transported on the
cell surface. The complex is recognized by TS2
cells and is activated. The activation of TS2 cells is
inhibited by anti-SF-Ab but not by anti-H-2K-Ab.
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On the other hand, suppression of neutralizing antibody
would delay elimination of DV from the body causing
pathological lesions (Chaturvedi, 1984; Chaturvedi et al.,
2006a). Furthermore, in certain strains of mice Delayed type
hypersensitivity (DTH) can be induced (Pang et al., 1982)
while in others this is not possible (Chaturvedi et al., 1977,
1978). In ‘nonresponder’ strains where the immune re-
sponse does not develop against an antigen the role of
suppressor cells has been suggested (Chaturvedi, 1984). In
primed mice DV-induced suppressor cells last for 3 weeks
and on adoptive transfer the suppressor activity of TS cells
persists for 3 weeks in recipient mice and that of SF1, TS2
and SF2 lasts 1–2 weeks (Shukla & Chaturvedi, 1985).
Suppressor T-cell activity, regulating B- and T-cell responses
in dengue type 3 virus-infected mice has been shown
(Nagarkatti & Nagarkatti, 1983). Induction of suppressor
cells in DV may suppress the cell-mediated immune re-
sponse and thus protect the body against T-cell-mediated
damage. Recently, the influence of human genes on DF and
DHF has been discussed revealing associations between
Human leucocyte antigen (HLA) polymorphism and dengue
disease susceptibility or resistance, protective alleles influen-
cing progression to severe disease, and alleles restricting
CD41 and CD81 T-cell and non-HLA genetic factors that
may contribute to DHF evolution, e.g. genes influencing
production of various cytokines (Chaturvedi et al., 2006b).
Table 2. Cytokine profile in patients with dengue
Cytokine Dengue fever Dengue haemorrhagic fever References
Interleukin-2 Marked increase Increased Kurane et al. (1991), Chaturvedi et al. (1999)
Interleukin-4 Increased Marked increase Chaturvedi et al. (1999)
Interleukin-6 Increased Marked increase Hober et al. (1993), Chaturvedi et al. (1999)
Interleukin-8 Decreased Marked increase Raghupathy et al. (1998)
Interleukin-10 Decreased Marked increase Chaturvedi et al. (1999)
Interleukin-12 Marked increase Decreased Pacsa et al. (2000)
Interleukin-13 Increased Marked increase Mustafa et al. (2001)
Interleukin-18 Increased Marked increase Mustafa et al. (2001, p. 58)
Interferon-g Marked increase Increased Kurane et al. (1991), Chaturvedi et al. (1999)
Tumour necrosis factor-a Marked increase Marked increase Hober et al. (1993), Chaturvedi et al. (1999)
Transforming growth factor-b Decreased Marked increase Agarwal et al. (1999b)
Cytotoxic factor Increased Marked increase Agarwal et al. (1998)
Mainly cited are those references which reported for the first time in human patients. These results have been confirmed in subsequent studies by
different groups.
Table 3. Effects of suppressor T cells on the severity of dengue disease
Functions of suppressor T cell
Effects of suppressor
T-cell activity
Effects on
disease severity References
Suppression of enhancing antibody Depressed opsonization of DV Protected Chaturvedi (1984)
Suppression of neutralizing antibody Depressed neutralization of DV Increased Chaturvedi (1984)
Suppression of hCF-autoantibody Increased production of hCF Increased Chaturvedi et al. (2001)
Suppression of cell-mediated immunity (DTH) Depressed opsonization of DV Increased/Protected Chaturvedi et al. (1978, 1884)
Suppression of Th1 response Depressed production of IFN-g, IL-2 Increased Chaturvedi et al. (2000)
Suppression of Th2 response Depressed production of IL-10, TGF-b Protective Chaturvedi et al. (2000)
Suppression of hCF-producing CD4 T cell Depressed production of hCF Protective Chaturvedi et al. (2000)
Suppression of IL-12 Depressed Th1 response Increased Chaturvedi et al. (2000)
Increased production of SF2
(prostaglandin-like) by TS2
Increased inflammatory response,
body pain
Increased Shukla & Chaturvedi (1981), Chaturvedi
et al. (1981), Shukla & Chaturvedi (1981)
Increased production of nitric oxide by
Mf exposed to SF1
Increased inflammatory response Increased Khare & Chaturvedi (1997)
Increased production of IL-10 by TS3? Increased inflammatory response Increased Mills (2004)
Increased production of TGF-b by TS3? Increased inflammatory response Increased Weiner (2001)
Increased phagocytosis by Mf-like cells Increased replication of DV Increased Nagar et al. (1985)
A cascade of cytokines produces the complex phenomenon of ‘cytokine tsunami’ that damages tissues, and absence of it helps in recovery from
immunopathology. No single cytokine can mediate this complex process.
Tr1 cells produce IL-10 and Th3 produce TGF-b. DV-induced TS3 may be Tr1 or Th3 or neither of them.
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This may also have a bearing on production of regulatory T
cells in DV infection. The role of suppressor/regulatory T
cells in dengue disease is summarized in Table 3.
Conclusions
Suppressor/regulatory T cells appear to play a key role in the
immunopathogenesis of severe dengue disease (DHF). The
biological significance of a multistep pathway is in self-
regulation and amplification of the signal. The product of
one T cell can activate more than 100 cells, thus amplifying
the signal. The data from mouse model cannot be extra-
polated to humans but they strongly indicate the possibility
of the existence of such a mechanism in humans that
determines the outcome of infection. There is a need to
investigate human cases of dengue infection on similar lines
using modern technology to identify markers on suppressor
T-cell subpopulations and characterize the suppressor fac-
tors. The paradigm of a shift from Th1 to Th2 cells in
patients with DHF needs re-examination in view of the
suggested role of the Th17 cell pathway (Steinman, 2007).
The future may see manipulation of the regulatory T-cell
subset for use in patients to treat pathological inflammatory
responses by enhancing/depressing their suppressive func-
tion. The suppression or depletion of regulatory T cells may
be employed to improve response to dengue vaccines. The
precise mechanisms that control regulatory T cells in vivo
are not clear. Several established immunomodulatory treat-
ments may influence regulatory T cells. In view of the fine
balance between upregulation and downregulation of cyto-
kine responses in dengue, as discussed above, the modifica-
tion of regulatory T cells in vivo will have to be approached
with caution to prevent any unwanted side-effects. Further
investigation into the development of new drugs that
enhance/depress the growth of regulatory T cells is crucial.
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